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The myeloma globulins formed in malignant plasma cells have particular 
importance as accessible and relatively discrete products of plasma cell metab- 
olism  which  closely  resemble  normal  immune  globulins.  Serum  myeloma 
proteins obtained from patients with multiple myeloma have been well charac- 
terized  and  immunochemical  differences  recognized  which  have  led  to  the 
division  of the myeloma proteins into two major groups,  usually designated 
gamma (~,) type and beta (fl2A) type myeloma proteins,  on the basis of dis- 
tinctive antigenic properties (1-4).  Identification of the two types of myeloma 
proteins  facilitated recognition  of  the  normal  fl2A-globulins as  one  of the 
human serum components  formed in plasma cells. Since ~2A-globulins had 
been identified only in human serum, it was not certain whether these proteins 
were unique to man or whether they occurred  in other species as well. The 
finding of similar globulins in the mouse in the course of the present studies, 
therefore,  was of particular interest. 
The recent discovery of transplantable plasma cell tumors (5-9)  and leuke- 
mias (10, 11)  in mice with associated  serum myeloma proteins and urinary 
Bence Jones proteins makes possible a new approach to the study in experi- 
mental animals of normal and malignant plasma cells and their metabolic 
products. 
The  present  studies  were  undertaken  to  determine  the  immunochemical 
characteristics  of  the  myeloma proteins  associated  with  20  transplantable 
plasma cell tumors from two strains of mice and to relate them to normal 
components of mouse serum.  In the course of this work it became  apparent 
that mouse myeloma proteins,  like human myeloma proteins,  could be divided 
into two groups  having distinctive antigenic and physicochemical properties. 
One group of myeloma globulins was closely related to the normal gamma glob- 
ulins of mouse  serum  but the other group  was related to a  separate normal 
serum component of beta mobility. 
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Methods 
Sera were obtained from mice bearing transplantable mouse plasma cell tumors which had 
been maintained by subcutaneous implantations of tumor fragments. 1 
Four of the tumors (5563, 5647, SPC-1, DPC-1) originated in C3H mice and  the remainder 
originated in BALB/c mice. The origin, biologic behavior, and  histological characteristics 
of these tumors have been or will be reported elsewhere (5-9, 12). Myeloma proteins or sera 
from mice bearing plasma cell tumors are designated by the name of the tumor, i.e., 5563 
myeloma proteins are associated with the 5563 plasma cell tumor. Normal mouse serum was 
obtained from CsH/He or BALB/c mice by cardiac puncture and the sera from each strain 
was pooled separately, frozen, and stored at --20°C until used for analysis. 
Immunoelectrophoresis was performed on microscope slides  by Wieme's modification of 
the technique of Scheldegger (13, 14) or on 31/~ X 4 inch photographic plates covered with 18 
ml of 1 per cent ionogarin 0.045  X veronai buffer.  A current of 1.5 ma/cm was employed for 
2 hours at room temperature in a box with high humidity to separate the protein components. 
The modified immunoelectrophoretic technique of Osserman (15) was employed to relate the 
myeloma proteins to components of normal serum. Ouchterlony double diffusion  analysis in 
agar plates was carried out as described previously (16). 
Antisera were produced  by immunizing rabbits  with normal  mouse serum  (4 rabbits), 
normal mouse gamma globulin (4 rabbits), 5563 myeloma protein (4 rabbits), 5647 myeloma 
protein (6 rabbits), and MPC-2 myeloma protein (2 rabbits). 2 
1 ml of serum or 2 to 5 mg of purified protein in 1 ml saline was emulsified  in 1 ml of com- 
plete Fretmd's adjuvant and injected into two intramuscular sites. This injection was repeated 
in 2 weeks and the rabbits were bled approximately 3 to 5 weeks later.  Some animals  also 
received a course of intravenous injections of alum-precipitated protein and were bled several 
times throughout the following week. 
Purified 5563 and MPC-11 myeloma proteins were prepared from serum by anion-exchange 
cellulose chromatography employing a  0.015  ~r to 0.05  ~t phosphate gradient  (16).  MPC-1, 
MPC-2, and 5647 myeloma proteins were prepared by a two step fractionation process em- 
ploying first zone electrophoresis of serum  on  polyvinyl chloride particle  (geon  426,  B. F. 
Goodrich Chemical Co., Cleveland)  blocks by  a  modification of  the  procedure  of  Mtlller- 
Eberhard and Kunkel (16, 17)  to obtain the electrophoretic fraction containing the myeloma 
globulin. This was subfractionated  by means of diethylaminoethyl  (DEAE)  cellulose chro- 
matography  employing a  gradient  elution  (16) from  0.04  ~x  to  0.30  M phosphate  pH  8 
buffer.  Each  purified  protein  was  characterized  by starch  gel  electrophoresis,  immuno- 
electrophoresis, and  ultracentrifugation and found to contain at least 95 per cent myeloma 
protein,  and  in  most preparations  no  contaminant  proteins were detected. Normal gamma 
globulin was obtained by eluting serial sections in the gamma globulin region after  block 
electrophoresis of normal or  hyperimmunized mouse sera. Each fraction was tested  by the 
Ouchterlony technique with rabbit antisera prepared  against mouse serum.  Only those elec- 
trophoretic fractions showing a  single (3')  precipitin line were pooled for subsequent  testing 
and use as gamma globulin. 
Tumors  5563,  5647,  MPC-1,  2,  11,  14,  and  15  were maintained  in this laboratory  by 
serial transplantation from tumors generously made available by R. Merwin and M. Potter. 
Sera from mice bearing the SPC-1 and DPC-1 tumors were made available by M. Potter and 
sera from mice bearing tumors MPC-3, 4, 5, 6, 7, 8,  16,  17,  19, 20, and  21 were made avail- 
able by R. Merwin. 
2 Eight of these antisera were prepared in association with Dr. Brigitte A. Askonas  (Na- 
tional Institute for Medical Research, London, England), who also kindly made available two 
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RESULTS 
Immunoelectrophoresis.--Immunoelectrophoresis  of  normal  mouse  serum 
revealed  multiple  components  among  the  normal  serum  proteins  (Fig.  1). 
In addition  to  the  normal serum components each myeloma serum showed a 
relatively dense precipitation arc indicating  the presence of myeloma globulin 
when an appropriate antisera was used (Figs.  1 to 3).  The myeloma globulins 
were  found  to  have  the  electrophoretic  mobility of "y-, fl-,  or o~-globulins  on 
immunoelectrophoresis in agreement with the electrophoretic mobility observed 
on paper or moving boundary electrophoresis (Fig. 4). The MPC-15 myeloma 
protein,  however,  migrated  very  little  on  immunoelectrophoresis  since  its 
FIG. 1. Immunoelectrophoresis  of normal mouse serum (NMS) and mouse myeloma sera 
(MPC-1). Electrophoresis was carried out in 0.045 ionic strength barbital buffer pH 8.6 and 
rabbit antisera prepared against normal mouse serum was allowed to diffuse from the central 
trough. The arrow indicates the precipitin arc due to the myeloma protein of alpha globulin 
electrophoretic mobility in MPC-1 serum. 
euglobulin properties caused it to precipitate in the 0.045  ionic strength buffer 
used (Fig. 3). 
The mouse myeloma proteins could be divided into  two groups, designated 
gamma and beta types on the basis of differences in the predominant antigenic 
properties. This difference is shown in Fig. 2 where two gamma type myeloma 
globulins,  5563  and  MPC-11,  are shown to  react  strongly  with  antisera  pre- 
pared against normal gamma globulin.  A similar reaction is seen when antisera 
to gamma myeloma proteins is used. These same myeloma globulins, however, 
react poorly with antisera prepared against beta type myeloma proteins (Fig. 
3).  Conversely, in Fig. 3,  two beta type myeloma proteins (5647  and MPC-1), 
are shown to react strongly with antisera prepared against beta type myeloma 
protein,  but  weakly  with  anti-gamma  antisera.  The  remaining  16  myeloma 
proteins, (SPC-1, DPC-1, MPC-2, 3, 4, 5, 6, 7, 8,  14,  15, 16, 17, 19, 20, and 21) 
reacted  well  with  antisera  to  beta  type  myeloma proteins  but  poorly  with 
antisera to gamma globulins. The reaction to antisera prepared against MPC-2 T
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myeloma protein is shown in Figs.  2 and 3 and similar reactions were observed 
to antisera  against  the 5647 myeloma protein. 
The  capacity  to  develop  plasma  cell  tumors  producing  gamma  or  beta 
myeloma protein  was present  in both  Call  and  BALB/c slrains  of mice since 
myeloma  proteins  of the  Call  tumor  5563  and  the  BALB/c  tumor  MP('-ll 
were gamma type globulins,  and beta type myeloma proteins were found with 
the Call tumors 5647, SPC-1, and DPC-1, and with most MPC lines of BALB c 
tumors.  Also,  the fact  that  antisera  prepared  against  myeloma globulins  from 
both  strains  of mice distinguished  between  the  two myeloma globulin  groups 
is  further  evidence that  strain  differences were not  responsible  for the gamma 
and  beta  type myeloma globulin differences. 
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Fi(;.  4.  Distrillution  of  20  myeloma  proteins  on  zone  electrol)horesis  in  conlparison  wifl~ 
l]le normal  mouse  serum  protein  pattern.  The  location  of  lhe  mid  portion  of  each  myehmm 
protein  peak  is indicated  by  one circle.  The  mid  portion  of  the peak  of  allmmin  was at  +70 
ram, alphas2 glolmlin  at  +48  ram, and beia globulin at -+-  17 ram. 
Rdalion  1o  Normal  Serum  Componenls.-  The  antigenic  relationship  of  the 
myeloma  proteins  to  normal  serum  components  was  shown  by  use  of  the 
immunoelectrophoretic  modification  introduced  by Osserman  (15).  In  Fig.  5, 
normal  mouse  serum  was  subjected  to  immunoelectrophoresis  and  from  ttle 
trough  on opposite  sides  of the  electrophuresed  serum  were  alh)wed  to diffuse 
purified  myeloma protein or antiserum tu mouse serum proteins.  When gamma 
type 5563 myeloma protein was allowed to diffuse from one trough and antisera 
from the uther,  the single precipitin  line running the length of the troughs and 
representing  the  gamma  myeloma protein  was  seen  to  react  with  the  normal 
gamma globulin  precipitin  arc  (t;ig.  ,5). 
Beta  type myeloma proteins,  however, were found to be closely related  to a 
normal  bela  globulin  component  and  not  to gamma globulin,  in  experiments 
such  as  that  illus/rated  in  Fig.  ,5.  In  this  test  agar  eleclrophoresis  of normal 
mouse serum was carried out in  the usual  way and a  mixture of antisera  versus ~66~ 
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normal mouse serum and antisera versus  beta  myeloma protein was added  to 
one  trough.  To  the  opposite  trough,  however,  was  added  purified  myeloma 
protein. Under these conditions a long transverse precipitin band representing 
lhe myeloma protein formed midway between lhe two troughs. As is shown in 
Fig. 5,  this horizontal band deviated toward The antibody lrough  in  the beta 
region, joining the precipitin band formed by a  normal serum component and 
indicating  the  presence in  normal  serum of a  normal  globulin  related  to  the 
Fro.  6.  Comparison of the normal beta gl/-~bulin component in  two  strains of mice.  Fresh 
sera ohtained from BALB/c and  C..~H/He  mice were used.  Purified  MPC-1  myeloma protein 
(0.3 mg/ml) was allowed to diffuse front the center trough and the tnixture of  rabbit  antisera 
to  normal mouse serum, and  to MPC-2  and  5647  myeloma proteins was added  to  the outer 
t roughs. 
beta myeloma protein. Myeloma proteins from different species (BALB/c and 
C:~H) and  differing electrophoretic mobility (5647  and  MPC-2  myeloma pro- 
teins migrate among the beta globulins and  MPC-1  myeloma protein among 
the alpha globulins)  reacted with the same beta  component of normal  serum 
(see Figs. 5 and 6). The gamma globulin precipitin arc was seen to pass through 
the beta myeloma precipitin band  (Fig. 5), further emphasizing the antigenic 
distinction between the gamma and beta globulin components. 
Strain differences in  the normal beta component were detected. When beta 
type myeloma proteins were reacted with fresh C:~H and  BALB'c serum after 
immunoelectrophoresis, shown in Fig. 6 for the MPC-1  globulin, the myeloma JOtIN  L.  FAHE¥  393 
protein reaction with the beta component in BALB/c serum was much more 
readily evident than with C3H serum. The same differences were observed with 
purified MPC-2 and 5647 (Fig. 5)  myeloma proteins and was not dependent 
upon the strain of origin of the myeloma protein or the type of antisera em- 
ployed. 
The beta type mouse myeloma proteins also showed a precipitin band that 
appeared to join with the albumin precipitin arc when antisera versus whole 
mouse serum was employed (Fig. 1). No reaction with albumin was observed, 
however,  when  antisera  against  beta  type  myeloma  proteins  (or  gamma 
globulin) was used (Figs. 2, 3). A similar observation was noted by Heremans 
(4) with beta-2A myeloma proteins in man. 
Comparison of Purified Myeloma Proteins.--Ouchterlony double  diffusion 
agar plates were used for direct comparison of four representative 7- and/3-type 
myeloma proteins.  By placing 7- and  /3-type  myeloma proteins  in  adjacent 
cups (Fig.  7 D, E)  and using suitable antisera,  the ~,-myeloma proteins  were 
shown to have antigenic sites that were not present on {3-type globulins (spur 
formation for the "y-myeloma protein,  Fig.  7 B).  Also  /3-myeloma  globulins 
were shown to have distinctive antigenic sites  that were not present on the 
"y-myeloma globulins (spur formation in  the precipitin bands for /3-myeloma 
proteins  in  Fig.  7 E)  or  normal  ")'-globulins.  This  illustration of distinctive 
properties by direct comparison of purified 7- and/3-myeloma proteins confirms 
the  immunoelectrophoretic  observation  that  these  two  types  of  proteins 
possessed  distinctive antigenic determinants. 
In addition to the specific antigenic determinants which permitted distinc- 
tion between the ~,- and/3-classes of myeloma protein, these classes  also were 
found  to  share  common antigenic sites.  A  precipitin  band,  such  as  that  il- 
lustrated in Fig. 7 E  between the anl.isera and the ~,- myeloma protein, which 
fused with but did not penetrate through the heavier precipitin band of the 
/3-globulin, indicated that the ~'-myeloma protein shared one or more antigenic 
determinants with the/3-myeloma globulin. Similarly, in Fig. 7 D a precipitin 
band  formed by the  /3-myeloma  protein  fused with  the  heavier ~,-precipitin 
band,  indicating that  an  antigenic determinant is  shared  by  the ~,-  and  /3- 
myeloma proteins. 
Proteins within the "}/- or /3-groups appeared to be closely related antigeni- 
cally. Fusion of precipitin bands formed by two adjacent 7- myeloma proteins 
(Fig. 7 A) and by two adjacent/3-myeloma proteins (Fig. 7 C) indicated that 
the  proteins  within  each  group  shared  antigenic  determinants.  Antigenic 
differences as well as  antigenic similarities were also  found when individual 
members of each group were compared further. The 5563 ~/-myeloma protein, 
for example,  is  shown by the  spur  formation in  Fig.  7 B  to  have antigenic 
determinants that are not shared by the MPC-11 ~,-myeloma protein. Similar 
differences were observed when individual/3-myeloma proteins were compared. T
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The  antigenic  complexity of  the  globulins  was  indicated  by  the  studies 
employing Ouchterlony double diffusion techniques. Six antigenic determinants 
would account for the distinctive as well as  the common antigenic sites ob- 
served in Fig. 7 and more antigenic determinants may well be involved. Anti- 
genic differences between individual globulins have already been demonstrated 
and  significant subdivisions within these groups may become apparent with 
further study. However, the validity of the general division of myeloma pro- 
teins into the two groups was supported by observations employing antisera to 
four different purified globulins, two of the "y-type and two of the/~-type. 
DISCUSSION 
Four classes of proteins, the 6.6  S "y-globulins,  the/~A-globulins,  the  18  S 
macroglobulins,  and  the  small,  Bence Jones  proteins,  have  been associated 
closely with plasma cells and related cells, principally on the basis of studies in 
man. These four classes (or their equivalents) also occur in the mouse. Both 6.6 S 
and macroglobulin antibodies have been identified in normal mouse serum (18) 
and Bence Jones proteins were found with a transplantable plasma cell tumor 
(6).  Beta  globulins  in  the  mouse,  equivalent  in  many respects  to the  /3,A- 
globulins of man, are described in the present report. 
Mouse  myeloma  proteins  were  immunochemically  classified  as  either  ~- 
or/~-type on the basis of distinctive antigenic features, and this immunochem- 
ical  classification has  been supported  and  extended by physicochemical ob- 
servations which indicate differences between the ultracentrifugal and starch 
gel  electrophoretic behavior and  the hexose content of these  two  groups of 
globulins  (19). The gamma type myeloma proteins were closely related anti- 
genically to the normal 6.6 S globulins which comprise the bulk of the electro- 
phoretic gamma globulin region. 
Beta type mouse myeloma proteins are related to a  normal serum compo- 
nent, not gamma globulin, which appears to be present in low concentration in 
normal serum. This component which migrates in the mid-beta globulin region 
in  fresh normal  serum  of  two  mouse strains,  could not  be termed a  beta-2 
globulin on the basis of electrophoretic mobility. Similarly, most of the myeloma 
proteins of this antigenic group are of mid- or fast-beta electrophoretic mobility 
(Fig.  4)  and  some are alpha globulins.  Therefore, the term E-type myeloma 
protein was used to indicate the predominant electrophoretic properties of this 
antigenically distinctive group of globulins? It  is  not intended,  however, to 
imply that all myeloma proteins in each category ('y or/~) will conform in all 
a Potter  and  Kuff  (20) employing immunoelectrophoresis with  antisera against tumor 
microsomal  preparations, studied the myeloma  proteins associated with 13 tumors in BALB/c 
mice, and divided the myeloma proteins between two immunoelectrophoretic  groups, desig- 
nated systems I and II. Their systems appear to be based on the detection of the antigenic 
properties, respectively,  of the gamma and beta type myeloma  globulins. 396  MOUSE  MYELOMA  PROTEINS 
features. Clausen et al.  (11),  for instance, have noted a myeloma protein with 
beta globulin electrophoretic mobility which was antigenically related to the 
gamma  globulins,  and  could  be  classified  immunoelectrophoretically as  a 
gamma type globulin. A variety of properties are to be expected for the myeloma 
proteins within each group as, indeed, was the case in the present study. 
Beta myeloma proteins are synthesized by the malignant plasma cells. That 
they do not result from conversion of 3'- to fl-type elsewhere in the body was 
shown by in vitro isotope incorporation studies with MPC-2 plasma cell tumor 
slices (21).  Since beta type myeloma proteins were shown to be synthesized in 
plasma cells it is reasonable to expect that the equivalent normal component 
is similarly synthesized in normal plasma cells. 
The evidence that each plasma cell tumor formed only 3'- or B-type myeloma 
protein (never both) would indicate that there may be two types of plasma 
cells, those forming "r- and those forming/~-type globulins. Why there should 
TABLE  I 
Frequency of Two Types of Plasma Cell Tumors 
Myeloma protein type  Man (38)*  Mouse (20)* 
per cen~  per ¢e~ 
Gamma ....................................  76  10 
Beta  (~A) ..................................  24  90 
* Number of patients and mouse tumors studied are given in parenthesis. 
be two classes of serum globulins formed in plasma cells is unknown. Since these 
two classes have been found in mouse and man, however, it may be expected 
that they will be recognized in other species as well. 
Other features of plasma cell malignancy may relate to whether a plasma cell 
tumor produces a ~/-type or/~-type myeloma protein. It has already been shown 
that normal gamma globulin catabolism is much more markedly accelerated 
by  plasma  cell  tumors  producing  gamma myeloma protein  than  by  those 
producing a beta myeloma protein in mice (22) and in man (23). 
Although the similarity of the two types of mouse myeloma proteins to the 
two types of myeloma proteins in man has been emphasized, the experience to 
date indicates one notable difference, i.e., in the frequency with which the two 
types are found. As shown in Table I, gamma myeloma proteins in man pre- 
dominate over beta type by a ratio of about 3 : 1, whereas in the mouse the ratio 
is more than reversed,  1:9.  It is not known whether this species  difference 
reflects  some  difference  in  the  site  at which  malignancy develops--intra- 
abdominally in the mouse and, apparently, in the bone marrow in man--or 
differences  in  the  conditions leading to  malignancy, or  some  other  factor. 
It  seems  clear,  however,  that  the frequency of each myeloma protein  type 
does not relate to relative amount of each of the equivalent globulins present JOttN L.  rAHEY  397 
in normal serum. Both man and mouse have much larger amounts of ~/- than 
fl (fl2a)-type globulins in normal serum and in both species most antibodies 
probably are among the 6.6S T-globulins. 
SUMMARY 
The serum myeloma proteins associated with 20 mouse plasma cell tumors in 
CsH or BALB/c mice that had proved transplantable were characterized by 
electrophoretic and immunochemical techniques. Although the myeloma pro- 
teins ranged in electrophoretic mobility from gamma to alpha globulins, they 
could be divided into two groups, the gamma type and the beta type myeloma 
globulins,  on the basis of characteristic immunochemical properties. Gamma 
type  myeloma  proteins  (5563,  MPC-11)  showed  a  close  immunochemical 
relationship to normal mouse gamma globulins. 
Eighteen  beta  type mouse  myeloma proteins  migrated  as  beta  or  alpha 
globulins  on  zone  electrophoresis. These proteins  shared  common antigenic 
features which  permitted  their  recognition, separate  from gamma  myeloma 
proteins. The beta type myeloma proteins were shown to be related to a beta 
globulin component present in normal serum. Strain differences were observed 
for the normal beta globulin component believed to be formed in plasma cells. 
The proteins formed in mouse plasma cells were found to be antigenically 
complex. Shared antigenic determinants as well as distinctive antigenic deter- 
minants  were  detected when representative myeloma proteins were purified 
and compared by the Ouchterlony double diffusion technique. 
The myeloma proteins associated  with  each of the  transplantable  plasma 
cell tumors in mice are regarded as distinctive and characteristic products of 
plasma  cell metabolism.  The variety of myeloma globulins  was  similar  for 
plasma cell tumors arising in Cj-I as well as in BALB/c mice, indicating that 
differences in mouse strains would not account for the differences among the 
myeloma  globulins.  These  differences,  however,  may  be  due  to  differences 
among the normal plasma cells from which the malignant cells are derived. If 
this is so, the variety of myeloma globulins reflect the variety of plasma cells 
present  normally. 
The author is indebted to Drs. M. Potter and Ruth Merwin for generous supply of sera 
from tumor-bearing mice and to Dr. Brigitte A. Askonas for assistance in obtaining antisera 
and for helpful discussions. The valuable assistance of Miss Mary E. Lawrence is gratefully 
acknowledged. 
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